Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit - Schedule of Stock Options Outstanding (Details)

v3.21.1
Shareholders' Deficit - Schedule of Stock Options Outstanding (Details) - USD ($)
3 Months Ended
Jun. 11, 2020
Mar. 31, 2021
Stock Option Outstanding, Granted 74,668,000  
Stock Options [Member]    
Stock Option Outstanding, Beginning Balance   3,014,080
Stock Option Outstanding, Granted  
Stock Option Outstanding, Cancelled   (350)
Stock Option Outstanding, Exercised  
Stock Option Outstanding, Ending Balance   3,013,730
Stock Option Outstanding, Exercisable Ending Balance   763,730
Weighted Average Exercise Price, Beginning Balance   $ 0.37
Weighted Average Exercise Price, Granted  
Weighted Average Exercise Price, Cancelled   47.00
Weighted Average Exercise Price, Exercised  
Weighted Average Exercise Price, Ending Balance   0.37
Weighted Average Exercise Price, Exercisable Ending Balance   $ 1.01
Weighted Average Remaining Contractual Term (years), Outstanding Beginning   1 year 8 months 2 days
Weighted Average Remaining Contractual Term (years), Granted   0 years
Weighted Average Remaining Contractual Term (years), Cancelled   0 years
Weighted Average Remaining Contractual Term (years), Exercised   0 years
Weighted Average Remaining Contractual Term (years), Outstanding Ending   2 years 9 months 14 days
Weighted Average Remaining Contractual Term (years), Exercisable   1 year 8 months 19 days
Aggregated Intrinsic Value, Outstanding Ending  
Aggregated Intrinsic Value, Exercisable Ending